Fortress Biotech (FBIO)
(Delayed Data from NSDQ)
$1.81 USD
-0.04 (-2.16%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.81 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Fortress Biotech, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
FBIO 1.81 -0.04(-2.16%)
Will FBIO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FBIO
Why Fast-paced Mover Fortress Biotech (FBIO) Is a Great Choice for Value Investors
Ultragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains?
FBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Despite Fast-paced Momentum, Fortress Biotech (FBIO) Is Still a Bargain Stock
Fortress Biotech (FBIO) Is Attractively Priced Despite Fast-paced Momentum
New Strong Sell Stocks for May 16th
Other News for FBIO
Fortress Biotech’s Subsidiary Merges with Sun Pharma
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics | FBIO Stock News
Wall Street Analysts Are Bullish on Top Healthcare Picks
Fortress Biotech Reports Q1 2025 Financial Highlights
Alliance Global Partners Sticks to Its Buy Rating for Fortress Biotech (FBIO)